{
    "nct_id": "NCT05307692",
    "title": "A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, and Clinical Efficacy of Seltorexant (JNJ-42847922) on Behavioral and Psychological Symptoms of Dementia in Patients With Probable Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2025-04-24",
    "description_brief": "The purpose of this study is to investigate the effect of seltorexant versus placebo on the sum of Agitation and Aggression domain scores (A plus A) of the Neuropsychiatric Inventory-Clinician rating (NPI-C) in participants with probable Alzheimer's Disease (AD) with clinically significant agitation/aggression.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "DB: Placebo",
                    "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                },
                {
                    "id": "FG001",
                    "title": "DB: Seltorexant",
                    "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                },
                {
                    "id": "FG002",
                    "title": "Follow-up (FU): Placebo",
                    "description": "After the completion of double-blind phase, participants entered the post-treatment follow up phase and were followed up until Day 57."
                },
                {
                    "id": "FG003",
                    "title": "FU: Seltorexant",
                    "description": "After the completion of double-blind phase, participants entered the post-treatment follow up phase and were followed up until Day 57."
                }
            ],
            "periods": [
                {
                    "title": "Double-blind (DB) Phase (Day 1- Day 43):",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "44"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "44"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Treated",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "42"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "43"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "39"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "35"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "9"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Protocol-specified withdrawal criterion met",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Other",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Randomized but not treated",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "FU Phase (Day 43 to Day 57):",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "39"
                                },
                                {
                                    "groupId": "FG003",
                                    "comment": "Three participants, who discontinued treatment during the DB phase (and so did not complete DB). They continued and entered the follow up phase.",
                                    "numSubjects": "38"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "39"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "34"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "4"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "3"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "Full analysis set included all randomized participants who took at least 1 dose of study intervention.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "DB: Placebo",
                    "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                },
                {
                    "id": "BG001",
                    "title": "DB: Seltorexant",
                    "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "42"
                        },
                        {
                            "groupId": "BG001",
                            "value": "43"
                        },
                        {
                            "groupId": "BG002",
                            "value": "85"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "72.6",
                                            "spread": "7.75"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "73.4",
                                            "spread": "6.18"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "73",
                                            "spread": "6.97"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Customized",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Adults (18-64 years)",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                },
                                {
                                    "title": "From 65 to 84 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "75"
                                        }
                                    ]
                                },
                                {
                                    "title": "85 years and over",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "28"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "54"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "16"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "39"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "82"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "41"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "78"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "UNITED STATES",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "85"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "Adults (18-64 years)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "From 65 to 84 years",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "75"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "85 years and over",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Neuropsychiatric Inventory Clinician Version (NPI-C) Sum of Agitation and Aggression Domain Scores (NPI-C A+A) at Day 43: Analyzed Under Estimand 1",
                    "description": "The NPI-12, measure of psychobehavioral disturbances assessed frequency and severity of disturbances in 12 domains, based on a caregiver interview. Frequency for each domain was rated on a 4-point scale (from 1=rarely to 4=very often) and severity on a 3-point scale (from 1=mild to 3=severe), with the score for each domain being product of frequency and severity scores, such that each domain was scored from 1 to 12. The NPI-12 total score was the sum of 12 domain scores, ranging from 0 (best) to 144 (worst), higher score represented greater frequency and worst severity of the symptoms. NPI-C was an instrument developed on basis of original NPI that gives a score based on product of frequency and severity ratings of 12 symptom domains that were summed to a total score. NPI-C domains: agitation and aggression NPI-C A+A were scored based on both caregiver and participant interviews and score ranged from 0 (does not occur) to 63 (severe). Higher scores indicated more severity.",
                    "populationDescription": "Full analysis set (FAS) included all randomized participants who took at least 1 dose of study intervention. 'N' (number of participants analyzed): participants evaluable for this outcome measure. Estimand 1 used to analyze benefit from seltorexant 20 mg versus placebo in adults and elderly participants with probable Alzheimer's disease (AD) with clinically significant agitation/aggression who took study intervention as directed and regardless treatment discontinuation without treatment switch.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline (Day 1) and Day 43",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "DB: Placebo",
                            "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                        },
                        {
                            "id": "OG001",
                            "title": "DB: Seltorexant",
                            "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "37"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "36"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-9.6",
                                            "spread": "8.35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-13.4",
                                            "spread": "9.31"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.308",
                            "statisticalMethod": "Mixed model repeated measures",
                            "paramType": "Difference of Least Square (LS) Means",
                            "paramValue": "-1.5",
                            "ciPctValue": "80",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-3.41",
                            "ciUpperLimit": "0.39",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.47"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in NPI-C A+A at Day 43: Analyzed Under Estimand 2",
                    "description": "The NPI-12, measure of psychobehavioral disturbances assessed frequency and severity of disturbances in 12 domains, based on a caregiver interview. Frequency for each domain was rated on a 4-point scale (from 1=rarely to 4=very often) and severity on a 3-point scale (from 1=mild to 3=severe), with the score for each domain being product of frequency and severity scores, such that each domain was scored from 1 to 12. The NPI-12 total score was the sum of 12 domain scores, ranging from 0 (best) to 144 (worst), higher score represented greater frequency and worst severity of the symptoms. NPI-C was an instrument developed on the basis of original NPI that gives a score based on product of frequency and severity ratings of 12 symptom domains that were summed to a total score. NPI-C domains: agitation and aggression NPI-C A+A were scored based on both caregiver and participant interviews and score ranged from 0 (does not occur) to 63 (severe). Higher scores indicated more severity.",
                    "populationDescription": "Full analysis set (FAS) included all randomized participants who took at least 1 dose of study intervention. 'N' (number of participants analyzed): participants evaluable for this outcome measure. Estimand 2 was used to analyze benefit from seltorexant 20 mg versus placebo in adults and elderly participants with probable AD with clinically significant agitation/aggression who took study intervention as directed and regardless of treatment discontinuation without treatment switch.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline (Day 1) and Day 43",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "DB: Placebo",
                            "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                        },
                        {
                            "id": "OG001",
                            "title": "DB: Seltorexant",
                            "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "38"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "36"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-9.6",
                                            "spread": "8.25"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-13.4",
                                            "spread": "9.31"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.282",
                            "statisticalMethod": "Mixed model repeated measures",
                            "paramType": "Difference of Least Square (LS) Means",
                            "paramValue": "-1.5",
                            "ciPctValue": "80",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-3.33",
                            "ciUpperLimit": "0.29",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.42"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in Cohen-Mansfield Agitation Inventory- Community Version (CMAI-C) Total Score at Day 43",
                    "description": "The CMAI-C, 37-item scale, measured the ability of a drug to reduce overall frequency of agitation symptoms, including aggressive behaviors. Individual items were rated by the clinician on a scale of 1 (never) to 7 (several times per hour) in which higher score represented the most frequent for each item assessed. CMAI-C total score was a sum of all categories that ranged from 37 (never) to 259 (several times), where higher score indicated greater severity.",
                    "populationDescription": "FAS included all randomized participants who took at least 1 dose of study intervention. Here, 'N' (overall number of participants analyzed) signifies participants who were evaluable for this outcome measure.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline (Day 1) and Day 43",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "DB: Placebo",
                            "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                        },
                        {
                            "id": "OG001",
                            "title": "DB: Seltorexant",
                            "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "38"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "36"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-17.5",
                                            "spread": "18.67"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-20.3",
                                            "spread": "21.69"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in Sleep Disorder Inventory (SDI) Average Total Score at Day 43",
                    "description": "SDI: based on caregiver (CG) interview and expanded version of item 11 (night-time behavioral disturbances) of NPI-12. It described frequency, severity and CG burden of sleep-disturbed behaviors for period prior to its administration. It consisted of 7 sub-questions from NPI-12 sleep disturbance item. Each sub-question was made into separate questions with frequency, severity, and CG distress rated with respect to participant. SDI score derived after CG rated frequency, severity of each of 7 separate sleep disturbance symptoms. CG distress ratings were not part of SDI total score, but distress was measured. Frequency scored on scale of 0 (not present) to 4 (once or more per day), severity scored on scale of 0 (not present) to 3 (occurrence of nighttime behaviors) and CG distress rated on scale of 0 (not at all) to 5 (extremely). SDI average total score=average frequency of item 1 to 7 multiplied with average severity of items 1 to 7; ranged from 0 to 12; higher score=greater severity.",
                    "populationDescription": "FAS included all randomized participants who took at least 1 dose of study intervention. Here, 'N' (overall number of participants analyzed) signifies participants who were evaluable for this outcome measure.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Score on a scale",
                    "timeFrame": "Baseline and Day 43",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "DB: Placebo",
                            "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42."
                        },
                        {
                            "id": "OG001",
                            "title": "DB: Seltorexant",
                            "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "36"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "36"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.8",
                                            "spread": "1.02"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.5",
                                            "spread": "0.90"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Observed Plasma Concentrations of Seltorexant and Its Metabolite (M12)",
                    "description": "The pharmacokinetic (PK) sample collection was done based on the availability of the participants either on Day 15 or 43 and thus collected data were analyzed and summary data were reported in this outcome measure. Plasma samples were analyzed using liquid chromatography/mass spectrometry/mass spectrometry (LC-MS/MS) method.",
                    "populationDescription": "The PK analysis set included all randomized participants to the seltorexant treatment group and with at least one PK sample taken. Here, 'N' (overall number of participants analyzed) signifies participants who were evaluable for this outcome measure.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "nanograms per milliliter (ng/mL)",
                    "timeFrame": "Either Day 15 (8 and 14 hours post dose on night of Day 14) or Day 43 (8 and 14 hours post dose on night of Day 42)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "DB: Seltorexant",
                            "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Total Seltorexant",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "121",
                                            "spread": "156"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total M12",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "141",
                                            "spread": "164"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Double-blind (DB) Phase: From Day 1 up to Day 43; Follow up Phase: From Day 44 to Day 57",
            "description": "All-cause mortality was anlyzed on all randomized participants. Serious adverse events and other adverse events were analyzed on safety analysis set which included all randomized participants who took at least 1 dose of study intervention.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "DB: Placebo",
                    "description": "Participants received placebo matching to seltorexant tablet orally once daily at bedtime from Day 1 to Day 42.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 44,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 42,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 42
                },
                {
                    "id": "EG001",
                    "title": "DB: Seltorexant",
                    "description": "Participants received seltorexant 20 milligrams (mg) orally once daily at bedtime from Day 1 to Day 42.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 44,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 43,
                    "otherNumAffected": 6,
                    "otherNumAtRisk": 43
                },
                {
                    "id": "EG002",
                    "title": "Follow-up (FU): Placebo",
                    "description": "After the completion of double-blind phase, participants entered the post-treatment follow up phase and were followed up until Day 57.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 39,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 39,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 39
                },
                {
                    "id": "EG003",
                    "title": "FU: Seltorexant",
                    "description": "After the completion of double-blind phase, participants entered the post-treatment follow up phase and were followed up until Day 57.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 38,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 38,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 38
                }
            ],
            "seriousEvents": [
                {
                    "term": "Pancreatic Neuroendocrine Tumour",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Ischaemic Stroke",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Atrial Fibrillation",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Supraventricular Extrasystoles",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Haemorrhoids",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Malignant Biliary Obstruction",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Bronchitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Nasopharyngitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Orchitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Contusion",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Neck Pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Tension Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Abnormal Dreams",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Confusional Arousal",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Dysphonia",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 38
                        }
                    ]
                },
                {
                    "term": "Pruritus",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA Version 26.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 42
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 43
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 39
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 38
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application."
            },
            "pointOfContact": {
                "title": "Study Director",
                "organization": "Janssen Research & Development, LLC",
                "email": "ClinicalTrialDisclosure@its.jnj.com",
                "phone": "844-434-4210"
            }
        }
    },
    "target_category": "neuropsychiatric symptom improvement",
    "drug": [
        "Seltorexant (JNJ-42847922 / MIN-202) \u2014 selective orexin\u20112 receptor (OX2R) antagonist, small molecule"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial primary outcome is the Agitation and Aggression domain (A + A) of the NPI\u2011C in probable AD patients, i.e., it is testing an effect on behavioral/neuropsychiatric symptoms rather than on amyloid, tau, or cognition. \ue200cite\ue202turn0search0\ue201",
        "Act \u2014 drug identity & mechanism: Seltorexant (JNJ\u201142847922, also MIN\u2011202) is a selective orexin\u20112 receptor antagonist that has been developed as a CNS\u2011active small molecule for sleep and mood indications. \ue200cite\ue202turn0search5\ue202turn0search1\ue201",
        "Act \u2014 drug type: Multiple sources list seltorexant as an investigational small\u2011molecule OX2R antagonist (chemical/monograph and clinical pharmacology reports). \ue200cite\ue202turn0search6\ue202turn0search3\ue201",
        "Interpretation/Matching to categories: Because seltorexant modulates the orexin (arousal/sleep/mood) system rather than targeting Alzheimer\u2019s pathology (amyloid or tau), and the trial endpoint is reduction of agitation/aggression (a behavioral symptom), the correct category is 'neuropsychiatric symptom improvement'. \ue200cite\ue202turn0search0\ue202turn0search5\ue201",
        "Reflect: No indication in the protocol that seltorexant is intended as a disease\u2011modifying biologic or small molecule targeting AD pathology, nor that it is primarily a cognitive enhancer. The classification as neuropsychiatric symptom improvement is therefore consistent with the intervention's mechanism and the trial's stated clinical endpoint. \ue200cite\ue202turn0search0\ue202turn0search5\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The investigational drug seltorexant (JNJ-42847922 / MIN-202) is a selective antagonist of the orexin-2 (OX2R) receptor \u2014 a CNS neuropeptide receptor involved in arousal, sleep/wake regulation, and mood. The trial tests reduction of agitation/aggression (behavioral/neuropsychiatric symptoms) in probable AD rather than targeting core AD pathologies (amyloid or tau). \ue200cite\ue202turn0search1\ue202turn0search2\ue201",
        "Act: Extracted facts \u2014 (1) Drug identity & mechanism: seltorexant (JNJ\u201142847922 / MIN\u2011202) is a small\u2011molecule, selective OX2R antagonist. \ue200cite\ue202turn0search1\ue202turn0search5\ue201 (2) Clinical context: seltorexant has been developed for sleep and mood indications and modulates the orexin (hypocretin) neurotransmitter system that regulates arousal and sleep/wake transitions, consistent with use to reduce agitation/behavioral symptoms. \ue200cite\ue202turn0search1\ue202turn0search3\ue201",
        "Reflect: Mapping to CADRO \u2014 orexin receptors are neurotransmitter/neuropeptide receptors. Within CADRO, interventions acting on CNS receptor systems (including neuropeptide receptors) are best classified under D) Neurotransmitter Receptors. Although orexin modulation also affects sleep/circadian processes, the most specific CADRO fit for an OX2R antagonist is D) Neurotransmitter Receptors (not a disease\u2011modifying amyloid/tau target, nor a diagnostic). The trial endpoint (behavioral symptom improvement) does not change that the molecular target is a neurotransmitter receptor. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Web search results supporting the above: (1) Translational Psychiatry / PubMed PMC article describing seltorexant as a selective OX2R antagonist with sleep\u2011promoting and antidepressant effects. \ue200cite\ue202turn0search1\ue202turn0search0\ue201 (2) Minerva Neurosciences / press material describing seltorexant (MIN\u2011202 / JNJ\u201142847922) as a selective orexin\u20112 receptor antagonist in development for mood and insomnia indications. \ue200cite\ue202turn0search3\ue201 (3) Drug databases / compound summaries (NCATS / probechem) listing seltorexant as an OX2R antagonist, binding data and pharmacology. \ue200cite\ue202turn0search5\ue202turn0search4\ue201",
        "Output: D) Neurotransmitter Receptors \u2014 Reasoning: seltorexant directly targets the orexin (OX2) receptor, a CNS neurotransmitter/neuropeptide receptor; the trial aims to reduce neuropsychiatric (agitation) symptoms, not to modify amyloid/tau pathology, so CADRO classification is D) Neurotransmitter Receptors."
    ]
}